Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.62
-0.08-2.96%
Protalix BioTherapeutics Inc (PLX) Stock Price, Quote, News & History
PLXAMEX
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Protalix BioTherapeutics (AMEX:PLX) through any online brokerage.
Other companies in Protalix BioTherapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Protalix BioTherapeutics has a consensus price target of $12.00.
The stock price for Protalix BioTherapeutics (AMEX: PLX) is $ last updated .
There are no upcoming dividends for Protalix BioTherapeutics.
Protalix BioTherapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Protalix BioTherapeutics.
Protalix BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
